Nakamura Y, Muguruma Y, Yahata T, Miyatake H, Sakai D, Mochida J, Hotta T, Ando K
Division of Hematopoiesis, Research Center for Regenerative Medicine, Tokai University School of Medicine, Isehara, Kanagawa 259-1193, Japan.
Br J Dermatol. 2006 Jun;154(6):1062-70. doi: 10.1111/j.1365-2133.2006.07209.x.
The identification and purification of keratinocyte stem cells (KSCs) that are capable of self-renewal and maintenance of differentiating cell populations could contribute both to our understanding of the biology of these cells, and to significant clinical applications, such as the culturing of keratinocytes for transplantation to severe burn wounds. Here, we report the detection of CD90(+) cells in cultured normal human epidermal keratinocytes and adult skin.
To investigate the biological function of CD90(+) and CD90(-) keratinocytes.
CD90(+) and CD90(-) keratinocytes were purified from adult skin and cultured keratinocytes using fluorescent activated cell sorting, and their biological abilities were analysed using both in vitro and in vivo assays.
Flow cytometry (FCM) analysis identified approximately 18% of post-primary neonatal keratinocytes as CD90(+). However, during expansion of the culture, the expression level of CD90 rapidly decreased to about 2.5% at passage 10, while most of the keratinocytes maintained expression of alpha6 integrin. Purified CD90(+) keratinocytes demonstrated a sixfold higher cell growth rate than CD90(-) cells and the ability to form large (over 3 mm in diameter) colonies. We then quantitatively evaluated both populations using a previously described in vivo human epidermal cyst formation assay. Enhanced green fluorescent protein (EGFP)-labelled CD90(+) or CD90(-) keratinocytes were subcutaneously injected into nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice. Six weeks after transplantation, EGFP(+) cell clusters in human epidermal cysts were evaluated using image analysis software. EGFP(+) cell cluster areas in the basal layer, derived from EGFP(+) CD90(+) cells, were eightfold larger than clusters of EGFP(+) CD90(-) cells. Furthermore, immunohistochemical staining and FCM analysis indicated that CD90 was expressed in most of the basal layer of the normal human epidermis.
These results indicated that CD90 is a useful marker for the detection of human KSC-enriched populations in cultured human keratinocytes.
能够自我更新并维持分化细胞群体的角质形成干细胞(KSCs)的鉴定和纯化,有助于我们了解这些细胞的生物学特性,并应用于重要的临床领域,如培养角质形成细胞用于移植到严重烧伤创面。在此,我们报告在培养的正常人表皮角质形成细胞和成人皮肤中检测到CD90(+)细胞。
研究CD90(+)和CD90(-)角质形成细胞的生物学功能。
使用荧光激活细胞分选技术从成人皮肤和培养的角质形成细胞中纯化CD90(+)和CD90(-)角质形成细胞,并通过体外和体内试验分析它们的生物学能力。
流式细胞术(FCM)分析显示,约18%的原代新生儿角质形成细胞为CD90(+)。然而,在培养扩增过程中,CD90的表达水平在第10代时迅速降至约2.5%,而大多数角质形成细胞维持α6整合素的表达。纯化的CD90(+)角质形成细胞的细胞生长速率比CD90(-)细胞高6倍,且具有形成大(直径超过3 mm)集落的能力。然后,我们使用先前描述的体内人表皮囊肿形成试验对这两种细胞群体进行定量评估。将增强型绿色荧光蛋白(EGFP)标记的CD90(+)或CD90(-)角质形成细胞皮下注射到非肥胖糖尿病/严重联合免疫缺陷(NOD/SCID)小鼠体内。移植6周后,使用图像分析软件评估人表皮囊肿中的EGFP(+)细胞簇。源自EGFP(+) CD90(+)细胞的基底层中EGFP(+)细胞簇面积比EGFP(+) CD90(-)细胞簇大8倍。此外,免疫组织化学染色和FCM分析表明,CD90在正常人表皮的大部分基底层中表达。
这些结果表明,CD90是检测培养的人角质形成细胞中富含人KSC群体的有用标志物。